S
Silvio Klugmann
Researcher at Vita-Salute San Raffaele University
Publications - 131
Citations - 6101
Silvio Klugmann is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Myocardial infarction & Aortic valve. The author has an hindex of 33, co-authored 131 publications receiving 5828 citations. Previous affiliations of Silvio Klugmann include University of Milan.
Papers
More filters
Journal ArticleDOI
Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis
Corrado Tamburino,Davide Capodanno,Angelo Ramondo,Anna Sonia Petronio,Federica Ettori,Gennaro Santoro,Silvio Klugmann,Francesco Bedogni,Francesco Maisano,Antonio Marzocchi,Arnaldo Poli,David Antoniucci,Massimo Napodano,Marco De Carlo,Claudia Fiorina,Gian Paolo Ussia +15 more
TL;DR: Benefit of TAVI with the CoreValve Revalving System is maintained over time up to 1 year, with acceptable mortality rates at various time points, although procedural complications are strongly associated with early mortality at 30 days.
Journal ArticleDOI
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
Patrick W. Serruys,Ben A. van Hout,Hans Bonnier,Victor Legrand,Eulogio García,Carlos Macaya,Eduardo Sousa,Wim Der Van Giessen,Antonio Colombo,Ricardo Seabra-Gomes,Ferdinand Kiemeneij,Peter Ruygrok,John A. Ormiston,Håkan Emanuelsson,Jean Fajadet,Michael Haude,Silvio Klugmann,Marie Angèle Morel +17 more
TL;DR: Over 12-month follow-up, a strategy of elective stenting with heparin-coated stents is more effective but also more costly than balloon angioplasty.
Journal ArticleDOI
Safety and Efficacy of the Subclavian Approach for Transcatheter Aortic Valve Implantation With the CoreValve Revalving System
Anna Sonia Petronio,Marco De Carlo,Francesco Bedogni,Antonio Marzocchi,Silvio Klugmann,Francesco Maisano,Angelo Ramondo,Gian Paolo Ussia,Federica Ettori,Arnaldo Poli,Nedy Brambilla,Francesco Saia,Federico De Marco,Antonio Colombo +13 more
TL;DR: This new technique allows patients with contraindications to the femoral approach to be treated with TAVI and appeared feasible and safe, with excellent procedural success and low in-hospital complication rates.
Journal ArticleDOI
Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.
Gian Paolo Ussia,Marco Barbanti,Anna Sonia Petronio,Giuseppe Tarantini,Federica Ettori,Antonio Colombo,Roberto Violini,Angelo Ramondo,Gennaro Santoro,Silvio Klugmann,Francesco Bedogni,Francesco Maisano,Antonio Marzocchi,Arnaldo Poli,Marco De Carlo,Massimo Napodano,Claudia Fiorina,Federico De Marco,David Antoniucci,Emanuela de Cillis,Davide Capodanno,Corrado Tamburino +21 more
TL;DR: This multicentre study demonstrates that TAVI with the 18-Fr CoreValve ReValving System is associated with sustained clinical and functional cardiovascular benefits in high-risk patients with symptomatic aortic stenosis up to 3-year follow-up.
Journal ArticleDOI
Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.
Carlos Macaya Miguel,Patrick W. Serruys,Peter Ruygrok,Harry Suryapranata,Silvio Klugmann,Philip Urban,Peter den Heijer,Karel T. Koch,Rüdiger Simon,Marie-Claude Morice,Peter Crean,Hans Bonnier,William Wijns,Nicolas Danchin,Claude Bourdonnec,Marie-Angèle Morel,Gijs Mast +16 more
TL;DR: Clinical follow-up data show that the benefit of elective native coronary artery stenting in patients with stable angina is maintained to at least 1 year after the procedure and results in a significantly reduced requirement for repeat intervention.